26894299|t|Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis.
26894299|a|Transthyretin (TTR) transports the retinol-binding protein-vitamin A complex and is a minor transporter of thyroxine in blood. Its tetrameric structure undergoes rate-limiting dissociation and monomer misfolding, enabling TTR to aggregate or to become amyloidogenic. Mutations in the TTR gene generally destabilize the tetramer and/or accelerate tetramer dissociation, promoting amyloidogenesis. TTR-related amyloidoses are rare, fatal, protein-misfolding disorders, characterized by formation of soluble aggregates of variable structure and tissue deposition of amyloid. The TTR amyloidoses present with a spectrum of manifestations, encompassing progressive neuropathy and/or cardiomyopathy. Until recently, the only accepted treatment to halt progression of hereditary TTR amyloidosis was liver transplantation, which replaces the hepatic source of mutant TTR with the less amyloidogenic wild-type TTR. Tafamidis meglumine is a rationally designed, non-NSAID benzoxazole derivative that binds with high affinity and selectivity to TTR and kinetically stabilizes the tetramer, slowing monomer formation, misfolding, and amyloidogenesis. Tafamidis is the first pharmacotherapy approved to slow the progression of peripheral neurologic impairment in TTR familial amyloid polyneuropathy. Here we describe the mechanism of action of tafamidis and review the clinical data, demonstrating that tafamidis treatment slows neurologic deterioration and preserves nutritional status, as well as quality of life in patients with early-stage Val30Met amyloidosis. 
26894299	48	57	Tafamidis	Chemical	MESH:C547076
26894299	61	97	Hereditary Transthyretin Amyloidosis	Disease	MESH:C567782
26894299	99	112	Transthyretin	Gene	7276
26894299	114	117	TTR	Gene	7276
26894299	158	167	vitamin A	Chemical	MESH:D014801
26894299	206	215	thyroxine	Chemical	MESH:D013974
26894299	321	324	TTR	Gene	7276
26894299	383	386	TTR	Gene	7276
26894299	478	493	amyloidogenesis	Disease	
26894299	495	499	TTR-	Gene	7276
26894299	507	518	amyloidoses	Disease	MESH:D000686
26894299	536	564	protein-misfolding disorders	Disease	MESH:D057165
26894299	662	669	amyloid	Disease	MESH:C000718787
26894299	747	769	progressive neuropathy	Disease	MESH:D018450
26894299	777	791	cardiomyopathy	Disease	MESH:D009202
26894299	871	886	TTR amyloidosis	Disease	MESH:C567782
26894299	958	961	TTR	Gene	7276
26894299	1000	1003	TTR	Gene	7276
26894299	1005	1024	Tafamidis meglumine	Chemical	MESH:C547076
26894299	1061	1072	benzoxazole	Chemical	MESH:D001583
26894299	1133	1136	TTR	Gene	7276
26894299	1221	1236	amyloidogenesis	Disease	
26894299	1238	1247	Tafamidis	Chemical	MESH:C547076
26894299	1313	1345	peripheral neurologic impairment	Disease	MESH:D010523
26894299	1430	1439	tafamidis	Chemical	MESH:C547076
26894299	1489	1498	tafamidis	Chemical	MESH:C547076
26894299	1515	1539	neurologic deterioration	Disease	MESH:D009422
26894299	1604	1612	patients	Species	9606
26894299	1630	1638	Val30Met	ProteinMutation	tmVar:p|SUB|V|30|M;HGVS:p.V30M;VariantGroup:0;CorrespondingGene:7276;CorrespondingSpecies:9606
26894299	1639	1650	amyloidosis	Disease	MESH:D000686
26894299	Association	MESH:D000686	HGVS:p.V30M;CorrespondingGene:7276
26894299	Negative_Correlation	MESH:C547076	HGVS:p.V30M;CorrespondingGene:7276
26894299	Negative_Correlation	MESH:C547076	MESH:D000686
26894299	Negative_Correlation	MESH:C547076	MESH:D010523
26894299	Association	MESH:D000686	7276
26894299	Negative_Correlation	MESH:D001583	7276
26894299	Association	MESH:C547076	7276
26894299	Association	MESH:D057165	7276
26894299	Negative_Correlation	MESH:C547076	MESH:C567782
26894299	Association	MESH:C000718787	7276
26894299	Association	MESH:D009202	7276
26894299	Negative_Correlation	MESH:C547076	MESH:D009422
26894299	Association	MESH:D000686	7276

